¼¼°èÀÇ ºÒÀÓ Ä¡·á ¼­ºñ½º ½ÃÀå
Fertility Services
»óǰÄÚµå : 1563832
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 193 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ºÒÀÓ Ä¡·á ¼­ºñ½º ½ÃÀåÀº 2030³â±îÁö 1,242¾ï ´Þ·¯¿¡ µµ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

2023³â¿¡ 470¾ï ´Þ·¯·Î ÃßÁ¤µÈ ºÒÀÓ Ä¡·á ¼­ºñ½º ½ÃÀåÀº 2030³â¿¡´Â 1,242¾ï ´Þ·¯¿¡ À̸£°í, ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)Àº 14.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ½Å¼±ºñµµ³Ê ¼­ºñ½º´Â º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 16.1%·Î ¼ºÀåÀ» Áö¼ÓÇϰí, ºÐ¼® ±â°£ Á¾·á ½Ã¿¡´Â 753¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ³Ãµ¿ ºñ°ø¿© ¼­ºñ½º ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 13.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 121¾ï ´Þ·¯, Áß±¹Àº º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 19.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¹Ì±¹ÀÇ ºÒÀÓ Ä¡·á ¼­ºñ½º ½ÃÀåÀº 2023³â 121¾ï ´Þ·¯·Î ÃßÁ¤µÆ½À´Ï´Ù. ¼¼°èÀÇ 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 317¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)Àº 19.3%ÀÔ´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)Àº °¢°¢ 10.2%¿Í 12.6%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 11.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ºÒÀÓ Ä¡·á ¼­ºñ½º ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ ¿ä¾à

ºÒÀÓ Ä¡·á ¼­ºñ½º´Â Àç»ý»ê °Ç°­°ú °¡Á· °èȹ¿¡ ¾î¶² Çõ¸íÀ» °¡Á®¿Ô´Â°¡?

ºÒÀÓ Ä¡·á ¼­ºñ½º´Â ÀÓ½ÅÀÇ °úÁ¦¿¡ Á÷¸éÇÏ´Â °³Àΰú Ä¿Çÿ¡°Ô °í±Þ ÀÇ·á °³ÀÔ°ú °³º° Äɾ Á¦°øÇÔÀ¸·Î½á »ý½Ä ÀÇ·á ¹× °¡Á· °èȹÀ» º¯È­½Ã۰í ÀÖ½À´Ï´Ù. ºÒÀÓ Ä¡·á¿¡ ´ëÇÑ Àνİú ¼ö¿ëÀÌ ³ô¾ÆÁö´Â °¡¿îµ¥ ü¿Ü¼öÁ¤(IVF), ³­ÀÚ µ¿°á, À¯ÀüÀÚ ½ºÅ©¸®´× µî º¸Á¶»ý½Ä±â¼ú ±â¼ú(ART)ÀÇ Áøº¸´Â ¼¼°èÀÇ ¼ö¹é¸¸ ¸íÀÇ »ç¶÷µé¿¡°Ô Èñ¸ÁÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ºÒÀÓ Ä¡·á ¼­ºñ½º¿¡´Â ºÒÀÓÀÇ Áø´Ü ¹× Ä¡·á, °¡Á· °èȹ Áö¿ø, »ý½Ä ±â´É °³¼± µî¿¡ µµ¿òÀÌ µÇ´Â ´Ù¾çÇÑ Ä¡·á°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ¼­ºñ½º´Â Çö´ë °Ç°­ °ü¸®¿¡¼­ ÇʼöÀûÀÎ ¿ä¼Ò°¡ µÇ°í ÀÖÀ¸¸ç, ³ªÀÌ¿Í º´¸®, ±âŸ ¿äÀο¡µµ ºÒ±¸ÇÏ°í °³Àΰú ºÎºÎ°¡ ºÎ¸ð°¡ µÇ´Â ²ÞÀ» ½ÇÇöÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÃÖ±Ù Ãâ»ê Áö¿¬, ¶óÀÌÇÁ ½ºÅ¸ÀÏ º¯È­, ºÒÀÓ·ü »ó½Â µîÀÇ »çȸÀû º¯È­·Î ÀÎÇØ ºÒÀÓ Ä¡·á ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ºÒÀÓ Ä¡·á Àü¹® Ŭ¸®´ÐÀº ºÒÀÓ ÆÇÁ¤°ú È£¸£¸ó Ä¡·áºÎÅÍ ÃÖ÷´Ü ART Ä¡·á±îÁö ´Ù¾çÇÑ ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. ƯÈ÷ ¹Ì·¡ÀÇ ÀÓ½ÅÀ» À§ÇØ »ý½Ä ´É·ÂÀ» À¯ÁöÇϰíÀÚÇÏ´Â ¿©¼ºµé »çÀÌ¿¡¼­ ³­ÀÚ µ¿°á Áõ°¡°¡ Å« µ¿ÇâÀ̵Ǿú½À´Ï´Ù. ÀÌ·¯ÇÑ ºÒÀÓ Ä¡·á ¼­ºñ½ºÀÇ È®´ë´Â °³ÀÎÀÌ »ý½Ä¿¡ ´ëÇÑ °Ç°­À» ÅëÁ¦ÇÏ´Â ÈûÀ» ÁÙ»Ó¸¸ ¾Æ´Ï¶ó, ƯÈ÷ µ¿¼º Ä¿ÇÃÀ̳ª ÆíºÎ¸ð, »ý½Ä¿¡ °üÇÑ °Ç°­ °úÁ¦¿¡ Á÷¸éÇϰíÀÖ´Â »ç¶÷µé¿¡°Ô °¡Á· °èȹÀ»º¸´Ù Ä£¼÷ÇÏ°í Æ÷°ý Çϰí ÀÖ½À´Ï´Ù. ºÒÀÓ Ä¡·á°¡ ÁøÀüµÇ°í »çȸÀûÀ¸·Î ¹Þ¾Æµé¿©Áö¸é¼­ ÀÌ·¯ÇÑ ¼­ºñ½º´Â »ç¶÷µéÀÌ °¡Á· °èȹÀ» ¼¼¿ì´Â ¹æ¹ý¿¡ À־ Çõ½ÅÀûÀÎ ¿ªÇÒÀ» ÇÕ´Ï´Ù.

¿Ö ºÒÀÓ Ä¡·á ¼­ºñ½º´Â »ý½Ä ¹®Á¦¸¦ ÇØ°áÇÏ°í °¡Á· °èȹ ¿É¼ÇÀ» ³ÐÈ÷´Â µ¥ Áß¿äÇմϱî?

ºÒÀÓ Ä¡·á ¼­ºñ½º´Â ÀÚ¿¬ ÀӽŠÀå¾Ö¿¡ Á÷¸éÇÏ´Â °³Àΰú ºÎºÎ¿¡°Ô ÀÇÇÐÀû ÇØ°áÃ¥À» Á¦°øÇϱ⠶§¹®¿¡ »ý½Ä ¹®Á¦¸¦ ÇØ°áÇÏ°í °¡Á· °èȹ ¿É¼ÇÀ» ³ÐÈ÷´Â µ¥ Áß¿äÇÕ´Ï´Ù. ¼¼°èÀÇÀûÀ¸·Î ¾à 10-15%ÀÇ Ä¿Çÿ¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ´Â ºÒÀÓÁõÀÇ À¯º´·üÀÌ Áõ°¡ÇÏ´Â °¡¿îµ¥ ºÒÀÓÄ¡·á ¼­ºñ½º´Â ÀÓ½ÅÀ» ¹æÇØÇÏ´Â ±âÃÊ ÁúȯÀ» Áø´Ü,Ä¡·áÇÔÀ¸·Î½á Èñ¸Á°ú Áö¿øÀ» Á¦°øÇÕ´Ï´Ù. ¿¬·É, È£¸£¸ó ±ÕÇüÀÇ È¥¶õ, À¯ÀüÀû ¿äÀÎ, »ýȰ ½À°ü ¹®Á¦ µî ºÒÀÓÀº Á¤½ÅÀûÀ¸·Î³ª À°Ã¼ÀûÀ¸·Î ºÎ´ãÀÌ µÇ´Â °ÍÀÔ´Ï´Ù. ü¿Ü¼öÁ¤(IVF), Àڱà ³» Àΰø¼öÁ¤(IUI), ³­ÀÚ¿Í Á¤ÀÚÀÇ Á¦°ø°ú °°Àº ºÒÀÓ Ä¡·á´Â ÀÌ·¯ÇÑ Àå¾Ö¸¦ ±Øº¹Çϰí ÀÓ½ÅÀ» ¼º°ø½Ãų ¼ö ÀÖ½À´Ï´Ù.

ºÒÀÓ Ä¡·á ¼­ºñ½º´Â ¶ÇÇÑ ºÒÀÓ¿¡ Á÷¸éÇÏÁö ¾Ê´õ¶óµµ °¡Á· °èȹÀ» À§ÇÑ ´ë¾ÈÀ» ã´Â »ç¶÷µé¿¡°Ô ¼±ÅñÇÀ» Á¦°øÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. °³ÀÎÀûÀÎ ÀÌÀ¯³ª °æ·Â»óÀÇ ÀÌÀ¯·Î Ãâ»êÀ» ´ÊÃß±â·Î ¼±ÅÃÇÑ ¿©¼ºÀº ³­ÀÚ µ¿°á¿¡ ÀÇÁ¸ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºÒÀÓ Ä¡·á ¼­ºñ½º´Â LGBTQÀÇ °³Àΰú Ä¿ÇÃ, °¡Á·À» ¸¸µé±â À§ÇØ ³­ÀÚ Á¦°ø, Á¤ÀÚ Á¦°ø, ´ë¸® Ãâ»êÀ» ÇÊ¿ä·ÎÇÏ´Â ÇÑ ºÎ¸ð¿¡°Ôµµ Áß¿äÇÑ ¿É¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼­ºñ½º´Â ºÎ¸ð°¡ µÇ´Â °ÍÀÌ »ý¹°ÇÐÀû Á¦¾àÀ̳ª ÀüÅëÀûÀÎ °¡Á· ±¸¼º¿¡ ÀÇÇØ Á¦ÇѵÇÁö ¾ÊÀ½À» º¸ÀåÇϸç, ¾î¸°À̸¦ °®±â À§ÇÑ º¸´Ù Á¾ÇÕÀûÀÌ°í ´Ù¾çÇÑ ±æÀ» Á¦°øÇÕ´Ï´Ù.

ºÒÀÓ Ä¡·á ¼­ºñ½ºÀÇ ¶Ç ´Ù¸¥ Áß¿äÇÑ ¿ªÇÒÀº ´Ù³¶¼º ³­¼Ò ÁõÈıº(PCOS), Àڱà ³»¸·Áõ, Á¤ÀÚ ¼ö ¹× ¿îµ¿·ü °¨¼Ò¿Í °°Àº ³²¼º ºÒÀÓÁõ°ú °°Àº ÀÇÇÐÀû Áõ»ó¿¡ ´ëÇÑ ´ëÀÀÀÔ´Ï´Ù. ºÒÀÓÄ¡·á Ŭ¸®´Ð¿¡¼­´Â Àӽа¡´É¼ºÀ» ³ôÀ̱â À§ÇÑ Ä¡·á³ª °³ÀÔÀ» ½Ç½ÃÇß½À´Ï´Ù. °Ô´Ù°¡, À¯ÀüÀÚ ½ºÅ©¸®´×°ú Âø»ó Àü À¯ÀüÇÐÀû °Ë»ç(PGT)ÀÇ Áøº¸´Â ÀӽŠÀü¿¡ À¯ÀüÀÚ ÁúȯÀ» È®ÀÎÇÒ ¼ö ÀÖ°Ô Çϰí, ºÎ¸ð¿Í ¾Æ±â ¸ðµÎ¿¡°Ô °Ç°­ÇÑ °á°ú¸¦ °¡Á®¿Ã ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÒÀÓ Ä¡·á¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ Á¢±Ù¹ýÀº ´õ ¸¹Àº »ç¶÷µéÀÌ º¹ÀâÇÑ »ý½Ä ¹®Á¦¸¦ ±Øº¹Çϰí ÀÌÀü¿¡´Â ºÒ°¡´ÉÇß´ø ¹æ½ÄÀ¸·Î °¡Á· Çü¼º ¿É¼ÇÀ» ³ÐÈ÷´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

¸®ÇÁ·Î´öƼºê Çコ¿¡¼­ ºÒÀÓ Ä¡·á ¼­ºñ½ºÀÇ È®´ëÇÏ´Â ÀÀ¿ë°ú Çõ½ÅÀ̶õ?

ºÒÀÓ Ä¡·á ¼­ºñ½ºÀÇ ÀÀ¿ë°ú Çõ½ÅÀº ÀÇ·á ±â¼ú, À¯ÀüÇÐ ¹× °³ÀÎÈ­µÈ »ý½Ä ÀÇ·áÀÇ ºñ¾àÀûÀÎ Áøº¸·Î ±Þ¼ÓÈ÷ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ºÒÀÓ Ä¡·á ¼­ºñ½º¿¡¼­ °¡Àå Áß¿äÇÑ Áøº¸ Áß Çϳª´Â ü¿Ü¼öÁ¤(IVF)ÀÇ »ó½ÂÀÔ´Ï´Ù. ü¿Ü¼öÁ¤(IVF)Àº ü¿Ü¿¡¼­ ³­ÀÚ¸¦ ¼öÁ¤ÇÏ°í ¼öÁ¤¶õÀ» Àڱÿ¡ À̽ÄÇÏ´Â ¹æ¹ýÀÔ´Ï´Ù. ±â¼úÀÌ ¹ßÀüÇÔ¿¡ µû¶ó ü¿Ü¼öÁ¤(IVF)ÀÇ ¼º°ø·üÀº Áõ°¡ÇÏ°í ºÒÀÓÀÇ °¡Àå È¿°úÀûÀÎ Ä¡·á¹ý Áß Çϳª°¡µÇ¾ú½À´Ï´Ù. Timelapse À̹ÌÁö ¹× ¹è¾Æ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ°ú °°Àº ±â¼ú Çõ½ÅÀ¸·Î ¹è¾Æ ¹è¾ç»ç´Â ¹è¾Æ ¹ß´ÞÀ» º¸´Ù Á¤È®ÇÏ°Ô Æò°¡ÇÒ ¼ö ÀÖ¾î Âø»ó°ú Àӽмº°ø È®·üÀÌ Çâ»óµÇ¾ú½À´Ï´Ù.

³­ÀÚ¿Í Á¤ÀÚÀÇ µ¿°á±â¼úµµ ´ëÆø °³¼±µÇ¾î ÀÓÈ¿¼º ¿ÂÁ¸ÀÇ ±âȸ°¡ ´Ã¾î³µ½À´Ï´Ù. À¯¸®È­¸¦ Æ÷ÇÔÇÑ µ¿°áº¸Á¸¹ýÀ» ÅëÇØ º¸´Ù ³ôÀº »ýÁ¸À²·Î ³­ÀÚ¿Í Á¤ÀÚ¸¦ µ¿°áÇÒ ¼ö ÀÖ¾î ºÎ¸ð°¡ µÇ´Â ½Ã±â¸¦ ´ÊÃß´Â À¯¿¬¼ºÀ» °³Àο¡°Ô Á¦°øÇÕ´Ï´Ù. À̰ÍÀº È­Çпä¹ý¿¡ ÀÇÇØ ÀӽżºÀ» ÀÒÀ» °¡´É¼ºÀÌ ÀÖ´Â ¾Ï ȯÀÚ³ª °³ÀÎÀû ¶Ç´Â ¾÷¹«»óÀÇ ÀÌÀ¯·Î ÀÓÈ¿¼ºÀ» ¿ÂÁ¸ÇÏ°í ½ÍÀº ¿©¼º¿¡°Ô ƯÈ÷ Áß¿äÇÕ´Ï´Ù. ¶ÇÇÑ Á¤ÀÚ ÃßÃâ ±â¼úÀÇ Áøº¸·Î Á¤ÀÚ ¼ö°¡ ÀûÀº ³²¼º°ú ´Ù¸¥ »ý½Ä ´É·Â¿¡ ¹®Á¦°¡ÀÖ´Â ³²¼ºµµ º¸Á¶»ý½Ä±â¼ú ±â¼ú¿¡ ÀÇÇÑ ÀÓ½ÅÀ» °¡´ÉÇϰÔÇÏ´Â ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù.

ºÒÀÓ Ä¡·á ¼­ºñ½ºÀÇ ¶Ç ´Ù¸¥ Çõ½ÅÀûÀÎ Çõ½ÅÀº Âø»ó Àü ¹è¾ÆÀÇ À¯ÀüÀÚ ½ºÅ©¸®´×À» °¡´ÉÇÏ°Ô ÇÏ´Â Âø»ó Àü À¯ÀüÇÐÀû °Ë»ç(PGT)ÀÔ´Ï´Ù. PGT´Â Àڱà Ãà³óÁõ, °â»ó ÀûÇ÷±¸ ºóÇ÷, ÇåÆÃÅϺ´ µîÀÇ ¿°»öü ÀÌ»óÀ̳ª À¯Àü¼º ÁúȯÀ» °ËÃâÇÒ ¼ö ÀÖ¾î, ü¿Ü¼öÁ¤(IVF)½Ã¿¡ °Ç°­ÇÑ ¹è¾Æ¸¸ÀÌ À̽ĵǴ °ÍÀ» º¸ÁõÇÕ´Ï´Ù. ÀÌ ±â¼úÀº Àӽмº°øÀÇ °¡´É¼ºÀ» ³ôÀϻӸ¸ ¾Æ´Ï¶ó À¯»ê°ú ¾î¸°ÀÌÀÇ À¯Àü ÁúȯÀÇ À§ÇèÀ» ÁÙÀÔ´Ï´Ù. À¯Àü »ó´ãÀº ÇöÀç ºÒÀÓ Ä¡·á ¼­ºñ½º¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀ̸ç, Ä¿ÇÃÀº À¯ÀüÀû üÁú¿¡ µû¶ó »ý½Ä ¼±Åÿ¡ ´ëÇÑ ÃæºÐÇÑ Á¤º¸¸¦ ¾òÀº ÈÄ¿¡ °áÁ¤ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ·¯ÇÑ ±â¼úÀû Áøº¸ ¿Ü¿¡µµ ºÒÀÓ Ä¡·á ¼­ºñ½º´Â »ý½Ä ÀÇ·á¿¡ ´ëÇѺ¸´Ù Á¾ÇÕÀûÀÎ Á¢±Ù ¹æ½ÄÀ¸·Î È®´ëµÉ Àü¸ÁÀ̰í ÀÖ½À´Ï´Ù. Ŭ¸®´ÐÀº ºÒÀÓ Ä¡·áÀÇ °¨Á¤Àû, ½ÅüÀû, ½É¸®Àû Ãø¸éÀ» ´Ù·ç´Â °ÍÀÇ Á߿伺À» ÀνÄÇÏ°í ºÒÀÓ Ä¡·á ÄÚĪ, ¿µ¾ç Áöµµ, Á¤½Å °Ç°­ »ó´ã, ħ¼ú°ú °°Àº Áö¿ø ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. ºÒÀÓ Ä¡·á Ŭ¸®´ÐÀº ¶ÇÇÑ ¿ø°Ý ÀÇ·á »ó´ã, ºÒÀÓ Ä¡·á ÃßÀû ¾Û, ¿ø°Ý ¸ð´ÏÅ͸µÀÌ ³Î¸® »ç¿ëµÇ´Â µî µðÁöÅÐ °Ç°­ µµ±¸¸¦ ÅëÇÕÇÕ´Ï´Ù. ÀÌ·¯ÇÑ È¯ÀÚ Áß½ÉÀÇ Ä¡·á·ÎÀÇ ÀüȯÀº º¹ÀâÇÑ ºÒÀÓ Ä¡·á ¿©ÇàÀ» ´õ Å« Áö¿ø°ú ÆíÀǼºÀ¸·Î Ž»öÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

ºÒÀÓ Ä¡·á ¼­ºñ½ºÀÇ Çõ½ÅÀÇ ¶Ç ´Ù¸¥ ºÐ¾ß´Â ºÒÀÓ Ä¡·á¿¡¼­ ÀΰøÁö´É(AI) ¹× ¸Ó½Å·¯´×ÀÇ »ç¿ëÀÇ È®´ëÀÔ´Ï´Ù. ÀΰøÁö´ÉÀÌÀÖ´Â ½Ã½ºÅÛÀº ȯÀÚ Á¤º¸, ¹è¾Æ ¹ß´Þ, Ä¡·á °á°ú µî°ú °°Àº ´ë±Ô¸ð µ¥ÀÌÅÍ ¼¼Æ®¸¦ ºÐ¼®ÇÏ´Â µ¥ »ç¿ëµÇ¸ç Àǻ簡 ºÒÀÓ Ä¡·á °èȹ¿¡ ´ëÇѺ¸´Ù Á¤È®ÇÑ ÆÇ´ÜÀ» ³»¸®´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¿¹¸¦ µé¾î, ÀΰøÁö´ÉÀº ȯÀÚÀÇ º´·Â, À¯ÀüÇÐ ¹× ¹è¾ÆÀÇ ÁúÀ» ±â¹ÝÀ¸·Î ü¿Ü¼öÁ¤(IVF)ÁÖ±âÀÇ ¼º°ø·üÀ» ¿¹ÃøÇÏ´Â µ¥ »ç¿ëÇÒ ¼ö ÀÖÀ¸¸çº¸´Ù °³ÀÎÈ­µÇ°í È¿°úÀûÀÎ Ä¡·á Àü·«À» °¡´ÉÇϰÔÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ºÒÀÓ Ä¡·á°¡ ´õ È¿À²ÀûÀÌ°í »ç¿ëÇϱ⠽±°í ¼º°øÇϱ⠽±°í °¡Á¤À» ±¸ÃàÇÏ·Á´Â °³Àΰú Ä¿Çÿ¡°Ô »õ·Î¿î °¡´É¼ºÀ» Á¦°øÇÕ´Ï´Ù.

ºÒÀÓ Ä¡·á ¼­ºñ½º ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀ̶õ?

ºÒÀÓ Ä¡·á ¼­ºñ½º ½ÃÀåÀÇ ¼ºÀå¿¡´Â ºÒÀÓÀÇ À¯º´·ü Áõ°¡, Ãâ»ê Áö¿¬, »ý½Ä ±â¼úÀÇ Áøº¸, ºÒÀÓ Ä¡·á¿¡ ´ëÇÑ »çȸÀû ¼ö¿ë Áõ°¡ µî ¸î °¡Áö Áß¿äÇÑ ¿äÀÎÀÌ ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎ Áß Çϳª´Â ¼¼°èÀÇ ºÒÀÓ Áõ°¡À̸ç, ÀÌ´Â ³²³à ¸ðµÎ¿¡°Ô ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¶óÀÌÇÁ ½ºÅ¸ÀÏ º¯È­, ȯ°æ ¿À¿° ¹°Áú, ½ºÆ®·¹½º, ºñ¸¸ ¹× ´Ù³¶¼º ³­¼Ò ÁõÈıº(PCOS)°ú °°Àº º´¸®Çаú °°Àº ¿äÀÎÀº ºÒÀÓ·ü »ó½Â¿¡ ±â¿©ÇÕ´Ï´Ù. ÀÚ¿¬ÀÓ½ÅÀÇ ¾î·Á¿ò¿¡ Á÷¸éÇÏ´Â »ç¶÷ÀÌ ´Ã¾î³²¿¡ µû¶ó ü¿Ü¼öÁ¤, IUI, ÀÓÈ¿¼º ¿ÂÁ¸ µîÀÇ Ä¡·á°¡ ÀϹÝÀûÀ¸·Î µÇ¾î ºÒÀÓÄ¡·á ¼­ºñ½º ¼ö¿ä´Â Áõ°¡ÀÇ ±æÀ» µû¶ó°¡°í ÀÖ½À´Ï´Ù.

ºÒÀÓ Ä¡·á ¼­ºñ½º ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©ÇÏ´Â ¶Ç ´Ù¸¥ Áß¿äÇÑ ¿ä¼Ò´Â Ãâ»ê Áö¿¬ÀÇ Ãß¼¼ÀÔ´Ï´Ù. °æ·Â, ±³À° ¹× °³ÀÎ ¸ñÇ¥¸¦ ¼±È£ÇÏ´Â ¿©¼ºÀÌ ´Ã¾î³ª´Â °¡¿îµ¥ ¸¹Àº ¿©¼ºµéÀÌ »îÀÇ ÈĹݿ¡ Àڳฦ °®±â·Î °áÁ¤Çß½À´Ï´Ù. ±×·¯³ª ƯÈ÷ ¿©¼º¿¡°Ô´Â ¿¬·É°ú ÇÔ²² »ý½Ä ´É·ÂÀÌ ÀúÇϵDZ⠶§¹®¿¡ ¿¬·ÉÀÌ ºÒÀÓÀÇ Áß´ëÇÑ ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ³­ÀÚ µ¿°á°ú ü¿Ü¼öÁ¤(IVF)À» Æ÷ÇÔÇÑ ºÒÀÓ Ä¡·á ¼­ºñ½º´Â »ý½Ä ´É·ÂÀ» À¯ÁöÇÏ°í »îÀÇ ÈĹݺο¡ ÀÓ½ÅÇϱ⸦ ¿øÇÏ´Â ¿©¼º¿¡°Ô ¼Ö·ç¼ÇÀ» Á¦°øÇϸç ÀÌ·¯ÇÑ ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î À̾îÁý´Ï´Ù. °Ô´Ù°¡, ÀçÈ¥°ú È¥ÇÕ °¡Á· Áõ°¡¿¡ µû¶ó, ºÒÀÓ Ä¡·á ¼­ºñ½º´Â ³ëÀÎ °³Àΰú ÇÔ²² ¾ÆÀ̸¦ °®°í ½Í¾îÇÏ´Â ºÎºÎ¿¡ ÀÌ¿ëµÇ°í ÀÖÀ¸¸ç, ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

»ý½Ä±â¼úÀÇ Áøº¸µµ ºÒÀÓÄ¡·á ¼­ºñ½º ½ÃÀå È®´ë¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. Âø»ó Àü À¯Àü ÇÐÀû °Ë»ç(PGT), ŸÀÓ ·¦½º ¹è¾Æ À̹Ì¡, µ¿°áº¸Á¸ ±â¼ú µîÀÇ Çõ½ÅÀûÀÎ Ä¡·á·Î ºÒÀÓ Ä¡·áÀÇ ¼º°ø·üÀÌ Çâ»óµÇ¾î »ý½Ä º¸Á¶¸¦ ¿ä±¸ÇÏ´Â °³Àΰú Ä¿Çÿ¡°Ô ´õ¿í ¸Å·ÂÀûÀ̵Ǿú½À´Ï´Ù. ºÒÀÓ Ä¡·á Ŭ¸®´Ð¿¡¼­ AI¿Í ¸Ó½Å·¯´×ÀÇ ÅëÇÕÀº º¸´Ù ¸ÂÃã Ä¡·á¸¦ Á¦°øÇϰí Ä¡·á Àü·«À» ÃÖÀûÈ­ÇÔÀ¸·Î½á Ä¡·á °á°ú¸¦ ´õ¿í Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀÇ Áøº¸´Â ºÒÀÓ Ä¡·á¸¦ ´õ È¿°úÀûÀ̰í Ä£¼÷ÇÏ°Ô ¸¸µé°í ´õ ¸¹Àº »ç¶÷µéÀÌ ºÒÀÓ Ä¡·á ¿É¼ÇÀ» ¸ð»öÇϵµ·Ï Ã˱¸ÇÕ´Ï´Ù.

ºÒÀÓ Ä¡·á¿¡ ´ëÇÑ »çȸÀû ¼ö¿ë Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. °ú°Å¿¡´Â ±Ý±â½ÃµÇ¾î ¿À¸íÀ» ÀÔÇô ÀÖ´ø ºÒÀÓÄ¡·áµµ ÇöÀç´Â ƯÈ÷ ¼±Áø±¹¿¡¼­ ³Î¸® ¹Þ¾Æµé¿©Áö°í ¹Þ¾Æµé¿©Áö°í ÀÖ½À´Ï´Ù. °øÀΰú À¯¸íÀÎÀÌ ºÒÀÓ Ä¡·á¿¡ ´ëÇØ °³¹æÀûÀ¸·Î ¸»ÇÔÀ¸·Î½á ºÒÀÓ¿¡ ´ëÇÑ Æí°ßÀÌ Èñ¹ÌÇØÁö°í, ´õ ¸¹Àº »ç¶÷µéÀÌ ºÒÀÓ Ä¡·á¸¦ ¹Þ°Ô µÇ¾î ÀÖ½À´Ï´Ù. ¶ÇÇÑ µ¿¼º °áÈ¥ ½ÂÀÎ, ´ë¸® Ãâ»ê ¹× ±âÁõÀÚ ÇÁ·Î±×·¥ÀÇ °¡¿ë¼º µî ¹ýÀû ¹× »çȸÀû Áøº¸´Â LGBTQÀÇ °³Àΰú ÇÑ ºÎ¸ð°¡ °¡Á·À» ±¸ÃàÇÒ ¼ö ÀÖ´Â »õ·Î¿î ±æÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Ä¡·á°¡ ´õ °¡±î¿öÁö°í Á¤»óÈ­µÊ¿¡ µû¶ó ºÒÀÓ Ä¡·á ¼­ºñ½º ½ÃÀåÀº °è¼Ó È®´ëµÇ°í ÀÖ½À´Ï´Ù.

ºÒÀÓ Ä¡·á¿¡ ´ëÇÑ Á¤ºÎ Áö¿ø°ú °Ç°­ °ü¸® Àû¿ë È®´ëµµ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¸¹Àº ±¹°¡¿¡¼­ º¸Çèȸ»ç¿Í °Ç°­ °ü¸® ½Ã½ºÅÛÀº ü¿Ü¼öÁ¤(IVF)°ú °°Àº ºÒÀÓ Ä¡·á¿Í °ü·ÃµÈ ºñ¿ëÀÇ ÀϺθ¦ ºÎ´ãÇϱ⠽ÃÀÛÇϰí ÀÖÀ¸¸ç, ´õ ¸¹Àº »ç¶÷µé¿¡°Ô ´õ ½±°Ô Á¢±ÙÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸®ÇÁ·Î´öƼºê Çコ¸¦ ÃßÁøÇÏ°í ºÒÀÓ Ä¡·á¿¡ ´ëÇÑ °æÁ¦Àû Áö¿øÀ» Á¦°øÇÏ´Â Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºêµµ ÀÌ·¯ÇÑ ¼­ºñ½º¿¡ ´ëÇÑ ¾×¼¼½º¸¦ ´Ã¸®´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. Ãâ»ý·üÀÌ ¶³¾îÁö´Â Áö¿ª¿¡¼­´Â Á¤ºÎ°¡ Àα¸ Áõ°¡¸¦ ÃËÁøÇÏ´Â ±¹°¡Àû ³ë·ÂÀÇ ÀÏȯÀ¸·Î ºÒÀÓ Ä¡·á¿¡ ÅõÀÚÇϰí ÀÖÀ¸¸ç ½ÃÀå È®´ë¿¡ ´õ¿í ±â¿©Çϰí ÀÖ½À´Ï´Ù.

°á·ÐÀûÀ¸·Î ºÒÀÓÁõÀ» ±Øº¹Çϰųª ºÎ¸ð°¡ µÇ´Â ½Ã±â¸¦ ´ÊÃ߰ųª ºñÀüÅëÀûÀÎ °¡Á·Çü¼ºÀÇ ¼±ÅÃÀ» Ãß±¸Çϱâ À§ÇØ »ý½Äº¸Á¶ÀǷḦ ¿ä±¸ÇÏ´Â °³Àΰú Ä¿ÇÃÀÌ ´Ã¾î³²¿¡ µû¶ó ºÒÀÓÄ¡·á ¼­ºñ½º ½ÃÀåÀº Å©°Ô ¼ºÀåÇϴ ż¼¸¦ Á¤µ·Çϰí ÀÖ½À´Ï´Ù. »ý½Ä±â¼úÀÇ Áøº¸, »çȸÀû ¼ö¿ëÀÇ È®´ë, ºÒÀÓÄ¡·á¼­ºñ½º¿¡ ´ëÇÑ Á¢±Ù Áõ°¡¿¡ ÀÇÇØ ÀÌ ¾÷°è´Â »ç¶÷µéÀÇ ÀÚº¸ÀÇ ²ÞÀÇ ½ÇÇöÀ» Áö¿øÇϴµ¥ À־ º¸´Ù Å« ¿ªÇÒÀ» ¿Ï¼öÇÏ°Ô µÉ °ÍÀÔ´Ï´Ù. ºÒÀÓ Ä¡·á°¡ °è¼Ó ÁøÈ­µÇ°í °³¼±µÊ¿¡ µû¶ó ´õ¿í Á¾ÇÕÀûÀ̰í È¿°úÀûÀÎ °³Àο¡ ¸Â´Â Ä¡·á°¡ Á¦°øµÇ¸ç ¼¼°èÀÇ »ý½Ä ÀÇ·á ¹× °¡Á· °èȹ »óȲ¿¡ Çõ¸íÀ» °¡Á®¿Ã °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÁÖ¸ñ 44»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

BJH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Fertility Services Market to Reach US$124.2 Billion by 2030

The global market for Fertility Services estimated at US$47.0 Billion in the year 2023, is expected to reach US$124.2 Billion by 2030, growing at a CAGR of 14.9% over the analysis period 2023-2030. Fresh Non-Donor Services, one of the segments analyzed in the report, is expected to record a 16.1% CAGR and reach US$75.3 Billion by the end of the analysis period. Growth in the Frozen Non-Donor Services segment is estimated at 13.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$12.1 Billion While China is Forecast to Grow at 19.3% CAGR

The Fertility Services market in the U.S. is estimated at US$12.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$31.7 Billion by the year 2030 trailing a CAGR of 19.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.2% and 12.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.4% CAGR.

Global Fertility Services Market - Key Trends and Drivers Summarized

How Are Fertility Services Revolutionizing Reproductive Health and Family Planning?

Fertility services are transforming reproductive health and family planning by offering advanced medical interventions and personalized care to individuals and couples facing challenges in conceiving. With increasing awareness and acceptance of fertility treatments, advancements in assisted reproductive technologies (ART), such as in vitro fertilization (IVF), egg freezing, and genetic screening, are giving hope to millions of people worldwide. Fertility services include a range of treatments that help diagnose and treat infertility, support family planning, and improve reproductive health. These services are becoming essential in the modern landscape of healthcare, allowing individuals and couples to realize their dreams of parenthood despite age, medical conditions, or other factors.

In recent years, the demand for fertility services has grown due to societal changes, such as delayed childbearing, lifestyle factors, and rising infertility rates. Fertility clinics now offer a wide array of services, from fertility assessments and hormonal treatments to cutting-edge ART procedures. The rise of egg freezing, particularly among women who wish to preserve their fertility for future pregnancies, has become a significant trend. This expansion of fertility services is not only empowering individuals to take control of their reproductive health but is also making family planning more accessible and inclusive, especially for same-sex couples, single parents, and those facing reproductive health challenges. As fertility treatments advance and societal acceptance grows, these services are playing a transformative role in how people plan their families.

Why Are Fertility Services Critical for Addressing Reproductive Challenges and Expanding Family Planning Options?

Fertility services are critical for addressing reproductive challenges and expanding family planning options because they offer medical solutions to individuals and couples who may face obstacles in conceiving naturally. With the increasing prevalence of infertility—affecting around 10-15% of couples globally—fertility services provide hope and support by diagnosing and treating underlying conditions that hinder conception. Whether due to age, hormonal imbalances, genetic factors, or lifestyle issues, infertility can be emotionally and physically taxing. Fertility treatments such as in vitro fertilization (IVF), intrauterine insemination (IUI), and egg or sperm donation enable people to overcome these barriers and achieve successful pregnancies.

Fertility services are also crucial in providing options for those who may not face infertility but are seeking alternatives for family planning. Women who choose to delay childbearing for personal or career reasons can now turn to egg freezing, which preserves their eggs at an optimal time, giving them the flexibility to conceive later in life. Additionally, fertility services offer crucial options for LGBTQ+ individuals and couples, as well as single parents, who may require donor eggs, sperm, or surrogacy to start a family. These services ensure that parenthood is not limited by biological constraints or traditional family structures, offering more inclusive and diverse pathways to having children.

Another key role of fertility services is in addressing medical conditions like polycystic ovary syndrome (PCOS), endometriosis, and male infertility issues such as low sperm count or motility. These conditions often go undiagnosed and untreated, but fertility clinics provide targeted treatments and interventions that increase the chances of conception. Furthermore, advancements in genetic screening and preimplantation genetic testing (PGT) allow for the identification of genetic disorders before pregnancy, ensuring healthier outcomes for both parents and babies. This comprehensive approach to fertility care is helping more people navigate complex reproductive challenges and expand their family-building options in ways that were not possible before.

What Are the Expanding Applications and Innovations in Fertility Services Across Reproductive Health?

The applications and innovations in fertility services are rapidly expanding, driven by breakthroughs in medical technology, genetics, and personalized reproductive care. One of the most significant advancements in fertility services is the rise of in vitro fertilization (IVF), which has revolutionized how couples and individuals approach infertility. IVF involves the fertilization of an egg outside the body, followed by the implantation of the embryo into the uterus. As technology improves, success rates for IVF have increased, making it one of the most effective treatments for infertility. Innovations such as time-lapse imaging and embryo monitoring systems allow embryologists to assess the development of embryos with greater precision, improving the chances of successful implantation and pregnancy.

Egg and sperm freezing technologies have also seen significant improvements, providing more opportunities for fertility preservation. Cryopreservation methods, including vitrification, have made it possible to freeze eggs and sperm with higher survival rates, offering individuals the flexibility to delay parenthood. This is particularly important for cancer patients who may face fertility loss due to chemotherapy, as well as women who want to preserve their fertility for personal or professional reasons. Additionally, advancements in sperm extraction techniques have provided solutions for men with low sperm counts or other fertility issues, allowing them to conceive through assisted reproductive technologies.

Another groundbreaking innovation in fertility services is preimplantation genetic testing (PGT), which allows for the genetic screening of embryos before implantation. PGT can detect chromosomal abnormalities or genetic disorders such as cystic fibrosis, sickle cell anemia, and Huntington’s disease, ensuring that only healthy embryos are transferred during IVF. This technology not only increases the chances of a successful pregnancy but also reduces the risk of miscarriage and genetic diseases in the child. Genetic counseling is now an integral part of fertility services, allowing couples to make informed decisions about their reproductive options based on their genetic makeup.

In addition to these technological advancements, fertility services are expanding to include a more holistic approach to reproductive health. Clinics are increasingly offering support services such as fertility coaching, nutritional guidance, mental health counseling, and acupuncture, recognizing the importance of addressing the emotional, physical, and psychological aspects of fertility treatment. Fertility clinics are also embracing digital health tools, with telemedicine consultations, fertility tracking apps, and remote monitoring becoming more common. This shift toward patient-centered care is helping individuals navigate the complex fertility journey with greater support and convenience.

Another area of innovation in fertility services is the growing use of artificial intelligence (AI) and machine learning in fertility treatments. AI-powered systems are being used to analyze large datasets of patient information, embryo development, and treatment outcomes, helping doctors make more accurate decisions about fertility treatment plans. For example, AI can be used to predict the success rates of IVF cycles based on patient history, genetics, and embryo quality, allowing for more personalized and effective treatment strategies. These innovations are making fertility treatments more efficient, accessible, and successful, opening up new possibilities for individuals and couples seeking to build families.

What Factors Are Driving the Growth of the Fertility Services Market?

Several key factors are driving the growth of the fertility services market, including the rising prevalence of infertility, delayed childbearing, advancements in reproductive technologies, and increasing societal acceptance of fertility treatments. One of the primary drivers is the growing global incidence of infertility, which is affecting both men and women. Factors such as lifestyle changes, environmental pollutants, stress, and medical conditions like obesity and polycystic ovary syndrome (PCOS) are contributing to rising infertility rates. As more people face challenges in conceiving naturally, the demand for fertility services continues to rise, with treatments like IVF, IUI, and fertility preservation becoming more commonplace.

Another significant factor contributing to the growth of the fertility services market is the trend toward delayed childbearing. With more women prioritizing their careers, education, and personal goals, many are choosing to have children later in life. However, age is a critical factor in fertility, particularly for women, as fertility declines with age. Fertility services, including egg freezing and IVF, provide solutions for women who wish to preserve their fertility and conceive later in life, leading to increased demand for these services. Additionally, with the rise in second marriages and blended families, fertility services are being used by older individuals or couples who wish to have children together, further driving market growth.

Advancements in reproductive technologies are also playing a crucial role in the expansion of the fertility services market. Innovations such as preimplantation genetic testing (PGT), time-lapse embryo imaging, and cryopreservation techniques have improved the success rates of fertility treatments, making them more appealing to individuals and couples seeking reproductive assistance. The integration of AI and machine learning in fertility clinics is further enhancing treatment outcomes by providing more personalized care and optimizing treatment strategies. These technological advancements are making fertility treatments more effective and accessible, encouraging more people to explore fertility options.

The growing societal acceptance of fertility treatments is another major factor driving market growth. Fertility treatments, once considered taboo or stigmatized, are now widely accepted and embraced, especially in developed countries. Public figures and celebrities openly discussing their fertility journeys have helped to reduce the stigma around infertility, encouraging more people to seek fertility services. Moreover, legal and social advancements, such as the recognition of same-sex marriages and the availability of surrogacy and donor programs, are providing new pathways for LGBTQ+ individuals and single parents to build families. As these treatments become more accessible and normalized, the fertility services market continues to expand.

Increasing government support and healthcare coverage for fertility treatments are also driving the growth of the market. In many countries, insurance companies and healthcare systems are beginning to cover a portion of the costs associated with fertility treatments like IVF, making them more affordable for a broader population. Government initiatives that promote reproductive health and provide financial assistance for fertility treatments are also helping to increase access to these services. In regions where fertility rates are declining, governments are investing in fertility treatments as part of national efforts to boost population growth, further contributing to the expansion of the market.

In conclusion, the fertility services market is poised for significant growth as more individuals and couples seek reproductive assistance to overcome infertility, delay parenthood, or pursue non-traditional family-building options. With advancements in reproductive technologies, growing societal acceptance, and increasing access to fertility services, the industry is set to play an even larger role in helping people realize their dreams of parenthood. As fertility treatments continue to evolve and improve, they will provide more inclusive, effective, and personalized care, revolutionizing the landscape of reproductive health and family planning worldwide.

Select Competitors (Total 44 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â